Race Oncology Limited (RAONF)
OTCMKTS
· Delayed Price · Currency is USD
1.220
0.00 (0.00%)
At close: Jul 11, 2024
Race Oncology Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
Cash & Equivalents | 17.19 | 17.19 | 21.52 | 33.54 | 9.32 | 1.73 | Upgrade
|
Cash & Short-Term Investments | 17.19 | 17.19 | 21.52 | 33.54 | 9.32 | 1.73 | Upgrade
|
Cash Growth | -20.13% | -20.13% | -35.84% | 259.79% | 438.63% | 75.05% | Upgrade
|
Other Receivables | 0.11 | 0.11 | 1.7 | 0.06 | 0.13 | 0.05 | Upgrade
|
Receivables | 0.11 | 0.11 | 1.7 | 0.06 | 0.13 | 0.05 | Upgrade
|
Prepaid Expenses | 0.12 | 0.12 | 0.32 | 0.55 | 1.14 | 0.03 | Upgrade
|
Other Current Assets | - | - | - | - | - | 0.18 | Upgrade
|
Total Current Assets | 17.42 | 17.42 | 23.54 | 34.15 | 10.59 | 2 | Upgrade
|
Other Intangible Assets | 2.81 | 2.81 | 3.09 | 3.37 | 3.66 | 3.94 | Upgrade
|
Total Assets | 20.23 | 20.23 | 26.64 | 37.52 | 14.25 | 5.93 | Upgrade
|
Accounts Payable | 1.2 | 1.2 | 0.64 | 0.83 | 0.31 | 0.13 | Upgrade
|
Accrued Expenses | 0.67 | 0.67 | 0.51 | 0.58 | 0.21 | 0.11 | Upgrade
|
Total Current Liabilities | 1.87 | 1.87 | 1.15 | 1.42 | 0.52 | 0.24 | Upgrade
|
Other Long-Term Liabilities | 0.05 | 0.05 | - | - | - | - | Upgrade
|
Total Liabilities | 1.92 | 1.92 | 1.15 | 1.42 | 0.52 | 0.24 | Upgrade
|
Common Stock | 66.95 | 66.95 | 61.71 | 62.02 | 31.5 | 19.66 | Upgrade
|
Retained Earnings | -57.42 | -57.42 | -43.6 | -33.68 | -22.47 | -15.77 | Upgrade
|
Comprehensive Income & Other | 8.78 | 8.78 | 7.38 | 7.77 | 4.69 | 1.8 | Upgrade
|
Shareholders' Equity | 18.31 | 18.31 | 25.49 | 36.11 | 13.72 | 5.69 | Upgrade
|
Total Liabilities & Equity | 20.23 | 20.23 | 26.64 | 37.52 | 14.25 | 5.93 | Upgrade
|
Net Cash (Debt) | 17.19 | 17.19 | 21.52 | 33.54 | 9.32 | 1.73 | Upgrade
|
Net Cash Growth | -20.13% | -20.13% | -35.84% | 259.79% | 438.63% | 75.05% | Upgrade
|
Net Cash Per Share | 0.10 | 0.10 | 0.13 | 0.22 | 0.07 | 0.02 | Upgrade
|
Filing Date Shares Outstanding | 170.39 | 170.39 | 163.07 | 159.52 | 144.4 | 122.77 | Upgrade
|
Total Common Shares Outstanding | 170.3 | 170.3 | 163.07 | 159.52 | 143.65 | 116.45 | Upgrade
|
Working Capital | 15.55 | 15.55 | 22.39 | 32.73 | 10.07 | 1.75 | Upgrade
|
Book Value Per Share | 0.11 | 0.11 | 0.16 | 0.23 | 0.10 | 0.05 | Upgrade
|
Tangible Book Value | 15.5 | 15.5 | 22.39 | 32.73 | 10.07 | 1.75 | Upgrade
|
Tangible Book Value Per Share | 0.09 | 0.09 | 0.14 | 0.21 | 0.07 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.